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ALTHOUGH such a wide variety of chemical substances has beeil tested for
carcinogenic activity, the group of lactones has been largely neglected. Thus,
Hartwell (1951) and Shubik and Hartwell (1957) together list 1329 plus 779, a
total of 2108, different compounds tested, but very few lactones appear in their
comprehensive Survey, and in almost all instances even these have Ilot been
tested over any adequate period for their possible carcinogenic action to have
been detected.
One of the very few lactones hitherto satisfactorily studied in this respect is
/J-propiolactone. This vesicant substance was found to be mutagenic in Neuro-
spora by Smith and Srb (1951), a finding which led Walpole et al. (1954) to study
the effect of prolonged subcutaneous injections extending over 13 weeks into rats
of/I-propiolactone, 2 mg./100 g. body weight, dissolved in arachis oil. Of 12 rats
so treated, 9 developed sarcomas at the injection site after 28 to 55 weeks from the
start of administration. Roe and Salaman (1955) decided that for the skin of
the mouse /&-propiolactone was undoubtedly an " initiator " in carcinogenesis
in the sense used by Friedewald and Rous (1944) giving tumours rapidly when
alternate treatments with croton oil as " promoter " were also given. At first
they expressed doubt whether /3-propiolactone is itself carcinogenic for the skin
of the mouse, but this was apparently due to too short a period of observation,
since Roe and Glendenning (1956) later observed tumours after 27-52 weekly
paintings of 2 5 per cent /J-propiolactone in acetone (papillomata arose in 5 mice
of 9 treated, becoming malignant in 2 mice after 40 weeks applications). With
higher initial doses, the early ulceration and scarring produced were followed by
earlier malignant change (3 carcinomas in 20 mice after 21 weeks). Consequently
/J-propiolactone must be considered definitely a carcinogenic substance, whether
given subcutaneously to rats or by application to the skin in mice. In either case
repeated applications are necessary for tumour production; fewer applications
than those given above have failed to produce tumours in mice (Salaman, 1959),
and this is also shown in the present paper to apply to subcutaneous injections
in the rat. This negative result was in fact to be anticipated from the short
period of persistence of the agent, due to the ease of breakdown of this unstable
lactone ring in the body (cf. Dickens, Jones and Williamson, 1956). This also
applies to a varying extent to the other lactones whose carcinogenic properties
are described in this paper, all of which were therefore applied repeatedly over
long periods, and usually from an oily depot to assist in slow liberation and
elimination.86 F. DICKENS AND H. E. H. JONES
Besides being mutagenic and carcinogenic, fl-propiolactone also possesses
anitibacterial and fungistatic properties (Bernherm and Gale, 1952 Gale, 1953).
It has been used for sterilizing plasma (Hartman, LoGrippo and Kelly, 1954) and
arterial grafts (Rains et al., 1956) and as a toxoiding agent (Orlans and Jones,
1958). Attention has been drawn by Roe and Salaman (1958) to the possible
hazard of using a carcinogenic agent for such purposes, and this aspect is also
reinforced by observations in the present paper.
The chemical reactivity offl-propiolactone is very high owing to the presence
of the highly strained four-membered lactone ring. A detailed physico-chemical
study by Bartlett and Small (1950) confirmed earlier findings that the reaction
with water molecules followed a unimolecular type of hydrolysis which was
inidependent of the concentration of added (perchloric) acid. On the other hand,
a variety ofnucleophilic reagents (acetate, halogen, thiocyanate, thiosulphate and
hydroxyl ions, in increasing order of reactivity) caused bimolecular displacement
(EN2 type) reactions with cleavage ofthe bond between thef8-carbon atom and the
alcoholic oxygen bond, a mechanism different in type from that of the normal
ester hydrolysis observed with the usual y- andd-lactones. This special type
ofreactivity is illustrated, forexample, by the fact that whereas in simple aqueous
solution fl-propiolactone becomes hydrolysed to fl-hydroxypropionic acid, in
aqueous solutions of ionized salts 3-substituted salts of propionic acid are pro-
duced, e.g. aqueous sodium chloride solution at room temperature yields primarily
sodiumf8-chloropropionate, together with some reaction-products resulting
from the further addition of fl-hydroxypropiolactone to the primary product
(Gresham et al., 1948).
In fact the reaction rates, as studied by Bartlett and Small (1950), off8-pro-
piolactone withnucleophilic reagents strongly resemble those for the attack of the
same reagents upon epichlorohydrin and fl-chloroethylethylene sulphonium ions:
types of chemical structure which are also associated with carcinogenic properties,
as in the chemically closely similar carcinogenic epoxides, ethyleneimines and
nitrogen mustards (cf. Walpole et al., 1954). The general chemical background
of these and other alkylating reagents in relation to their cytotoxic properties
has been extensively reviewed by Ross (1953) and most of his conclusions may
reasonably be applied to the cytotoxic and carcinogenic effects of f-propiolactone.
As one example of this type of reactivity, we have studied the interaction of
cysteine with f-propiolactone which occurs readily at approximately neutral pH
in aqueous solution, and have isolated the product in crystalline form as briefly
described by Dickens, Jones and Williamson (1956): in the present paper this
compound is shown to be identical with S-2-carboxyethyl-L-cysteine, as recently
synthesized by a different route by Mamalis, McHale and Green (1960). Conse-
quently the product is now shown to be a thioether, in which the sulphur of the
cysteine is bound directly to the f-carbon of the propiolactone with opening of
the lactone ring. Similar reactions of the ionized thiol group ofcysteine with
mustard gas, nitrogen mustards and epoxides are reviewed by Ross (1953).
The property of reacting in this manner with substances such ascysteine is
also shown by a range of antibacterial substances. The antibacterial action of
fl-propiolactone has already been mentioned. Similarly, the penicillins also
contain a reactive four-memberedring which is present in this case as a substituted
lactam structure: Penicillin also reacts vigorously with cysteine in aqueous
solution, whereby it loses its bacteriostatic properties. The chemistry of this
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reaction has recently been carefully studied by Nakken, Eldjarn and Pihl (1960)
who conclude that the rate-limiting step is a bimolecular reaction involving the
mercaptide ion. These authors refer to the widely held view that the antibiotic
action of penicillin and its specific binding to sensitive bacteria may involve a
reaction with the 8I-lactam ring. In view of these similarities with ,8-propio-
lactone, we have tested penicillin G for its possible carcinogenic activity. Two
substituted derivatives of /?-propiolactone have also been similarly tested.
It is known that a range of unsaturated gamma and delta lactones also exhibit
marked pharmacological activities (for a review see Haynes, 1948). The activities
recorded include selective inhibition of the growth of animal tissues, antibiotic
activity, inhibition of germination of seeds and of plant growth, and other varied
and striking pharmacological effects. Particularly active selective growth in-
hibitors were certainacf/-unsaturated &-lactones and a &-pentenolactone. In some
cases a protective influence of alanine and glutathione could be demonstrated
(Haynes, 1948), while cysteine (but not cystine) was antagonistic to the &-hexeno-
lactone. This compound was shown to react with the thiol group, and cysteine
counteracted the biological effect of the lactone. It was therefore thought
(Haushka, Toennies and Swain, 1945) that this substance exerted its effect on
cellular proliferation mainly through its action upon essential thiol groups in the
organism affected. A naturally occurring unsaturated lactone probably resembl-
ing in structure the above compounds was originally shown to have selective
inhibitory effects on the growth in cultures of connective tissue, while permitting
free growth of epithelial tissue, by Medawar, Robinson and Robinson (1943).
Growth inhibitory effects in young animals, and in Jensen sarcoma in rats, by
a factor obtained from malt extract, later tentatively identified by Medawar et al.
(1943) as the 8-lactone of 5-hydroxyhex-2-enoic acid, had been previously reported
by Heaton (1929 see also Medawar, 1937). The long-known dextrorotatory
form of this lactone (parasorbic acid) has been isolated and clearly identified
from berries of the mountain ash by Kuihn and Jerchel (1943) and has been found
to exert similar growth-inhibitory properties (Kuihn et al., 1943) to those of the
synthetic DL-isomer.
From bacteriological studies, a rather closely related series of lactones as well
as the above lactone of 5-hydroxyhex-2-enoic acid have been found to exhibit
antibiotic properties. Among this series of compounds (Haynes, 1948), sub-
stituted4fl-unsaturated lactones, especially those with an unsaturated side chain
such as protoanemonin, the y-lactone of 4-hydroxy-penta-2,4-dienoic acid, ob-
tained originally from Ran: nculus and Anemone species, show marked antibiotic
activity. Penicillic acid and patulin are actively antibiotic naturally occurring
unsaturated lactones, of which the activity is also abolished by treatment with
amino compounds and also with cysteine: patulin is rather toxic; the lethal
dose for mice is stated to be 0-2 mg., whereas that for penicillic acid is 7 mg. The
reaction of these two antibiotics with cysteine has been studied by Geiger and
Conn (1945) who also describe a group of synthetic oc,-unsaturated ketones
possessing varying degrees of antibiotic activity; all the active compounds were
shown to react with cysteine with loss of the sulphydryl group as shown by the
nitroprusside test. Cavallito and Haskell (1945) examined the reaction products
obtained when the weakly antibiotic so-called ac- and 8-angelica lactones (see
formulae, Tables I and II) reacted with cysteine and related compounds. The
primary reaction was thought to be addition of the thiol group to the double bond
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TABLE I.-Formulae of Compounds Tested for Carcinogenic Activity
in the Rat
o-co
(a) Carcinogenic compounds / C
ICH
CH2 CH2 HC C
0 CO H2C CH (OH)
0
1I
CH3
C\ C OCH3) CH CH
C-C(OH) CH/
CH3.CH C CO
CH2 O ~Co 0
III IV
CH=CH CH2 CH2
CH3aCH2CX,CO CH3.CH CH 0
V VI
(CH3)2C CH.COONa
/ \ C6H5.CH CH.COOH
CH 0 C
VIII
Vll CH.NH.CO.CH1.C6H5
fH2 C(C6H5)2 HOOC.CH2.CH2\
0 CO HOOC.CH(NH2).CH2/
Ix x
(b) Non-carcinogenic
CH-CH\ CH-CH2
CH3CXH2.C.,JO CH3.C lco
0 0
xi xli
H2 CO
Xlii
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of the lactones. Saturated lactones (y-valerolactone) did not react with cysteine,
and methylation of the thiol group in cysteine blocked the reaction with angelica
lactone. The amino group (e.g. in alanine) did not react directly with these
lactones, but the amino group in cysteine did react secondarily after addition of
this compound to the double bond in a-angelica lactone, forming a cyclic lactam,
which was isolated (Cavallito and Haskell, 1945).
These chemical constitutions and reactivities ofthe group ofbiologically active
unsaturated lactones have been considered here because they formed the basis of
selection of compounds which we have tested for their possible carcinogenic action
in the rat. A very wide range of such compounds has been investigated by other
workers in connection with their antibacterial action, but an arbitrary selection
had to be made from those compounds which were available to us at the time this
work began. For comparison, a few less reactive lactones have been included in
the series tested. The formulae of the compounds which we have tested for
carcinogenic activity are given in Table I.
Nomenclature of lactones used
Because of the confusion introduced by several different systems of nomen-
clature oflactones, the systematic names corresponding to the formulae of Table I
are given in Table II. These are based on the Chemical Society's current usage
with the advice of Dr. R. S. Cahn and for brevity the trivial names, also given ili
Table II, are generally used in this paper.
TABLE II. Nomenclature of the Compounds Listed in Table I
No. Systematic name Trivial name used in this paper
I 3-Hydroxypropionic acid lactone . Propiolactone.
II Patulin (Clavacin).
III Penicillic acid.
IV . 4-Hydroxyhexa-2,4-dienoic acid lactone Methyl protoanemonin.
V 4-Hydroxyhex-2-enoic acid lactone the 2-hexenoic lactone.
VI 4-Hydroxyhex-4-enoic acid lactone the 4-hexenoic lactone.
VII Sodium benzylpenicillinate Penicillin G (sodium salt).
VIII 2-Carboxy-3-phenyl-3-hydroxypropionic a-Carboxyf-phenyl-fl-propiolactone.
acid lactone
IX 2,2-Diphenyl-3-hydroxypropionic acid . aa-Diphenyl-fl-propiolactone.
lactone
X S-2-Carboxyethyl-L-cysteine the thioether (condensation product)
XI 4-Hydroxyhex-3-enoic acid lactone the 3-hexenoic lactone.
XII 4-Hydroxypent-3-enoic acid lactone a-Angelica lactone.*
XIII 3-Hydroxybutyric acid lactone y-Butyrolactone.
* So-called "f-Angelica lactone
" is the 4-Hydroxyhex-2-enoic acid lactone, i.e. the double bond
is in fact at the a-position, while that in a-angelica lactone is at the fl-position, owing to unfortunate
historical naming of these compounds.
EXPERIMENTAL
All melting points recorded are uncorrected.
Materials. /,-Propiolactone, a-angelica lactone and y-butyrolactone were
purchased from L. Light and Co. and purified by fractional distillation under
diminished pressure.
Patulin (clavacin), m.p. 109-111°, was kindly supplied by Prof. J. H. Birkin-
shaw, and a second sample of patulin, m.p. 109-1IO', was kindly given by Boots
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Pure Drug Co., Ltd. Both specimens appeared equally active carcinogenically
in the doses used.
Penicillic acid monohydrate, m.p. 62-640 was also a gift from Professor Bir-
kinshaw (Birkinshaw, Oxford and Raistrick, 1936).
Lactones IV (methylprotoanemonin), V (2-hexenoic lactone), VI (4-hexenoic
lactone) and XI (3-hexenoic lactone) were generously supplied by the Badische
Anilin-und Soda-fabrik A.G., Ludwigshafen, through the kindness of Prof. H.
Oettel. The 2- and 3-hexenoic lactones were prepared as described in Beilstein's
Handbuch, 17, 2 Erg. Werk, p. 297. Methylprotoanemonin was prepared from
dehydrogenating dehydration of ,-propionylpropionic acid (DAS 1088,047).
The identity ofthese lactones was kindly confirmed by Dr. A. E. Kellie in this
Institute by measurements of the infra-red absorption spectra.
Penicillin G (crystalline sodium salt of benzyl penicillin, B.P.) containing
1670 international units/mg. was a well known commercial preparation.
,f-Phenyl-a-carboxy-/I-propiolactone and aa-diphenyl-fl-propiolactone were
given by Imperial Chemical Industries through the courtesy of Dr. A. L. Walpole.
The preparation of S-2-carboxyethyl-L-cysteine from /,-propiolactone and
cysteine is described in this paper. The product, m.p. 210-212° decomp. was re-
crystallized from water before use. Dr. P. Mamalis of Vitamins Ltd. very kindly
provided a comparison specimen ofthis substance and of its N-benzoyl derivative,
and also carried out infra-red absorption spectrum identification on our product.
Animal Experiments
Two-month-old male rats for injection, weighing about 100 g., and 4-week-old
female rats of about 50 g. for transplantation experiments were obtained from
our own closed breeding colony of animals derived from the Wistar strain. Alto-
gether 295 rats were used.
All substances tested for carcinogenic activity were injected twice weekly
into subcutaneous sites in the right flank of the male rats. Repetitive injections
into each animal were made as nearly as possible into the same place. When open
abscesses developed in any rat as a result of these injections the treatment was
withheld from that animal until healing occurred and then resumed as in the rest
of the group. Most of the injections were made with a solution of the substance
in 0-5 ml. arachis oil, and oil alone was injected into the control rats.
,8-Propiolactone was administered in doses of 1 mg. and 0-1 mg. in oil and
2 mg. in water. The latter was a freshly prepared solution for each injection in
order to minimize the amount of hydrolysis which occurred before injection.
One group of animals was treated with this substance in oil for only 4 weeks, but
the treatment of all the other groups with this and other substances was con-
tinued until tumours developed, or for as long as our supply of the substances
lasted, or for a maximum period of about 60 weeks. The two samples of patulin
supplied by Messrs. Boots and Prof. Birkinshaw respectively were tested at doses
of 0-2 mg. in oil. Ten times this amount at each injection proved to be lethal to
the rats. The 4-hydroxyhexenoic lactone series, which includes the 2-, 3- and
4-hexenoic lactones, and methyl protoanemonin were used at doses of 2 mg. in
oil unless rats died, when a lower dose was used. 8-phenyl-a-carboxypropio-
lactone was not freely soluble in oil and, in this case, the saturated oily layer
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over an excess of the substance was used for injection. Penicillin G was also
insoluble in oil and was injected as a finely ground suspension.
Rats which did not develop tumours within the maximum treatment period
were kept under observation until complete absorption of the oil from the site of
injection could be demonstrated or the animals died. All rats which survived
about 100 weeks were killed at this time and examined post mortem for the
presence of abnormalities or tumours.
Suspected tumours were fixed in formol saline for histological study. Small
pieces of selected tumours from each group were implanted subcutaneously by
trochar into young female rats and their ability to grow recorded over a period of
3 months. Successful transplants were not normally re-implanted.
RESULTS
Tumours developed (Table III) in male rats treated by repeated injections with
patulin, /J-propiolactone, occz-diphenylpropiolactone, f-phenyl-a-carboxypropio-
lactone, the 2- and 4-hexenoic lactones, penicillic acid, penicillin G, methyl proto-
anemonin and the condensation product offi-propiolactone with cysteine.
The most effective of these substances as a carcinogenic agent was f8-propio-
lactone which, in oil, gave rise to the appearance oftumours in all the rats treated
with a total dose of 5*0 mg. or more over a minimum period of 25 weeks. There
was no significant difference in the period required for tumours to appear in groups
treated with 1 mg./injection for 29 weeks, with 0.1 mg./injection for 25 weeks
or with 2-0 mg. in water/injection for 33 weeks. However, the aqueous solution
of this substance was more prone to produce ulceration at the site of injection
than the oily solution, making it more difficult to produce uniform exposure ofthe
tissues to its influence. This may be partly responsible for the lower incidence
oftumours in this group. /J-propiolactone in oilused at a level of0*2 mg./injection
was ineffective when the treatment was only continued for 4 weeks. The com-
pound of this substance with cysteine also produced a significant reduction in its
carcinogenic activity, the only tumour produced arising 35 weeks after the com-
pletion of 52 weeks' injections in the sole survivor after this long period.
The carcinogenic properties ofnone of these substances except ,8-propiolactone
have been reported previously.
The great majority of tumours obtained (Table IV) were present at the site
ofthe injection. They were nearly all fibroblastic tumours with varying amounts
ofcollagen formation and were classified as spindle cell sarcomas, fibrosarcomas or
myxosarcomas (Fig. 1-6). A large number of the tumours were found to be
capable ofcontinued growth as a transplant, andin one instance a tumour obtained
by treatment with penicillic acid was maintained as a transplant through twelve
generations without marked histological change (cf. Fig. 2 and 6). All the
primary tumours showed a sufficient degree of variation in cell size and staining
and mitotic activity to justify a histological diagnosis ofmalignancy, though they
did not appear to behave with a high degree of malignancy since for the most
part they did not invade the surrounding muscle and subcutaneous tissues, and
even massive growths showed no sign of metastasizing. Many of the tumours
showed moderate or severe necrosis or calcification when examined.
Penicillin G was found to give rise to two fibrosarcomas at the site ofinjection,
one of which showed a strong ability to grow as a transplant. The rats bearing
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TABLE III.-The Carcinogenic Action of a Series of Compounds Administered
Twice Weekly by Subcutaneous Injection to Male Rats
Amount
Dura- at each
tion of injection
treat- (in oil
ment unless
(weeks) stated)
54 . 0 5 ml.
61
61
fl-Propiolactone . I 44
34
33
4
Patulin (Boots) II Toxic
( ,, ) . . 61
(Birkinshaw) . . 64
Penicillic acid . III 64
Methyl protoanemonin . IV . 64
2-Hexenoic lactone . V . 64
4-Hexenoic lactone VI . 58
5
54
Penicillin G (Na salt) VII . 46
52
a-Carboxy-fl-phenyl-fl- . VIII . 64
propiolactone
aa-Diphenyl-,B-propio- IX . 19
lactone
S-2-Carboxyethyl-L- . X 52
cysteine
3-Hexenoic lactone XI 64
a-Angelica lactone . XII 61
y-Butyrolactone . . XIII 61
-1-0mg.
0-1 mg.
2-0mg.
(aqueous)
0-2 mg.
22-0 mg.
0-2 mg.
0-2 mg.
1-0 mg.
2-0 mg.
22-0 mg.
1-0 mg.
2-0 mg.
2-0 mg.
2-0 mg.
2-0 mg.
Sat. sol.
in oil
(<2 mg.)
1-0 mg.
0-5 mg.
2-0 mg.
2-0 mg.
2-0 mg.
Earliest
appear-
ance of
tumours
(weeks)
107
29
25
31
58
62
48
61
79
63
93
59
84
91
Number
of rats
alive at
time of
tumour
appear-
ance*
6t
5
3
10:
4
4
5
4
4
4
5
4
5
2
4
4
4
4
Number
of rats Total
develop- period
ing observed
tumours (weeks)
0 54
o . 61
1 107
(in thorax)
10 44
4 . 34
2 . 55
0 . 52
4 69
2 . 64
4 . 67
3 105
2 . 102
3 . 99
0 . 51
0 . 93
3t . 100
-1 . 105
1 . 105
89 . 3 . 1 105
87 . 1 1 . 87
2
5
5
0
0
0
105
100
100
* Or at end of observation period, where no tumours developed.
t Tumours included a thyroid alveolar carcinoma and a fibroma at a subcutaneous site remote
from the injections and a fibrosarcoma at the injection site.
t Groups of 5 rats were used in all experiments except a group of 6 for oil controls and a group of
10 for fl-propiolactone.
EXPLANATION OF PLATES
FIG. 1.-Actively proliferating sarcoma from the injection site of a male rat treated with 0 2
mg. patulin in oil twice a week for 62 weeks. This tumour did not grow as a transplant.
x400.
FIG. 2.-Scar tissue with proliferating fibrosarcoma from the injection site of a male rat treated
with 1 mg. penicillic acid in oil twice a week for 48 weeks. This tumour grew well in 4 of 5
rats as a transplant. x 400.
FIG. 3.-Actively proliferating fibrosarcoma from the injection site of a male rat treated with
2 mg. methyl protoanemonin in oil twice a week for 64 weeks. The tumourappeared 8 weeks
after the injections had stopped and grew well in all of 6 young female rats into which it was
transplanted. x 400.
FIG. 4. Proliferating fibrosarcoma from the injection site of a male rat treated with 2 mg.
penicillin G in oil twice a week for 45 weeks. The tumour appeared 27 weeks after the
injections had stopped and did not grow as a transplant, unlike the second fibrosarcoma
arising in the penicillin series which grew well on transplantation. x 400.
FIG. 5. Fibroma obtained from the uninjected flank of a male rat treated with 2 mg. peni-
cillin G in oil twice a week for 45 weeks and observed for a further 14 weeks. The rat did
not have tumours at the injected site, or elsewhere, when killed. The tumour did not grow
as a transplant. x 400.
FIG. 6.-Tumour after 12 successive transplantations of fibrosarcoma obtained from injection
site of rat treated with penicillic acid (Fig. 2). This tissue shows an accelerated rate of
growth in 100 per cent of the recipients but has not suffered any histological change. x 400.
Substance
tested
Controls-Arachis oil
No. in
Tables
I and
II
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these tumours had been given about 200 mg. penicillin (about 330,000 i.u.) over
a period of about 50 weeks. Another rat in this treatment group which had
received 184 mg. penicillin over a period of 46 weeks developed a large fibroma
in the subcutaneous tissues of the flank which had not received the injections.
No mitoses were seen in the sections examined and the tumour did not survive
transplantation. A fourth rat survived 100 weeks after receiving 184 mg. peni-
TABLE IV. Characteristics of Tumours Produced by Male Rats by Repeated
Subcutaneous Injections of Lactones and Related Compounds
Substance injected
Arachis oil .
fl-Propiolactone (I)
(aqueous)
Patulin (Boots) (II)
(Birkinshaw) (II)
Penicillic acid (III)
Methyl protoanemonin (IV)
2-Hexenoic lactone (V)
4-Hexenoic lactone (VI)
PenicillinG (VII)
(1670 i.u./mg.)
ditto
ditto
ditto
a-Carboxy-fl-phenyl-fl-
propiolactone (VIII)
aa-Diphenyl-/3-propio-
lactone (IX)
S-2-Carboxyethyl-L-cysteine.
(X)
Develop- Weight of Histology
Total dose ment time tumour of
(mg.)
(61 ml.)
58
58
66
70
70
68
72
72
76
86
5
6-2
6-8
6-8
124
124
23-2
24-4
24-4
24-4
24-8
25-6
96
116
128
128
244
256
256
256
256
116
116
116
184
184
208
184
?
38
52
(weeks) (g.) tumour
107 . . Thoracic
tumour*
29 52 . Fibrosarcoma
29 . ? . ?
33 . ? . ?
35 . 15 .
35 . 10 .
34 . 26 .
36 . 54 ?
36 . 35 . ?
38 . 30 . ?
43 . 50 . ?
25 . 9 . Fibrosarcoma.
31 . 20 . ?
34 . 14 . Sarcoma
34 . 12 .
31 8 .
63 . 50 .
58 15 . Fibrosarcoma.
62 17 . ,
65 29 . ,
65 . 11 . Sarcoma
62 10 . Fibrosarcoma
64 4-5 .
48 35
58 21 .
67 7 .
67 15 . Sarcoma
61 21 Fibrosarcoma
72 . 33 .
83 . 24 .
79 . 15 .
83 . 75 .
63 . 19 . Sarcoma
72 . 13- 5 . Fibrosarcoma
95 . 13 . Sarcoma
59 . . Fibroma*
72 . 5-5 . Fibrosarcoma
84 13-5 . ,
100 . Thyroid
carcinoma*
91 13 . Fibrosarcoma
89 . 13 . Myxosarcoma.
87 . 41 . Sarcoma
Takes in
rats of
transplants
NA
NA
NA
NA
2/2
2/2
NA
NA
NA
NA
1/2
NA
7/12
NA
3/10
NA
5/10
3/12
NA
NA
NA
0/6
0/6
4/5
0/6
6/6
4/6
6/6
3/6
0/6
1/7
0/6
0/6
2/6
2/6
0/6
0/6
5/6
NA
5/6
0/5
1/6
NA Not attempted.
*-Tumours which developed at sites remote from the injections.
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cillin over a period of 46 weeks and at post mortem an enlarged lobe of the thyroid
was found. Histological examination showed this to be a carcinoma of the epi-
thelial cells of the thyroid follicles similar to the thyroid tumours which Lindsay,
Potterand Chaikoff (1957) have reported to be of spontaneous origin in about
33 per cent of untreated animals examined by them. In contrast to this we have
dissected out the thyroids of some hundreds of rats from our colony varying in age
from 6 months to well over one year and have never noticed a similar condition.
We rarely have the opportunity to examine the thyroids of rats which are 2 years
old as was this penicillin treated rat. In this series of experiments, however, over
50 rats were examined which were more than 20 months old and in this selection
no other thyroid tumours were found. Whether the thyroid tumour resulted
from the penicillin treatment or not it is therefore impossible to say.
There were no tumours found in the oil-injected controls examined at 54 and 61
weeks after the treatment commenced. Among five rats which survived for more
than 95 weeks after the oil injections were started there were no tumours at the
site of the injections, but one of three rats which survived 107 weeks was found to
have a dark red fleshy nodule inside the thoracic cavity, attached to the costal
muscle layer, and lying to the right side of the vertebral column at the level of the
thoracic vertebrae5-6-7. This nodule appears to be malignant in that it is not
encapsulated and has infiltrated local adipose tissue. Its cells resemble para-
thyroid tumour, but are not typical of functioning parathyroid cells. Again, a
tumourof this type has not been detected in any other rats which have been
examined in this laboratory.
Other abnormalities found were: the presence ofpyelonephritis in the kidneys
of two rats treated respectively with1 mg. of the 4-hexenoic lactone twice weekly
for 58 weeks and 2 mg. methyl protoanemonin twice weekly for 64 weeks. Both
these rats were examined after the experiment had continued for about 100 weeks.
One rat treated with 2 mg. of the 3-hexenolactone twice weekly for 64 weeks
and examined 41 weeks later showed evidence ofperitonitis with adhesions between
the intestine and the abdominal wall, extreme bronchiectasis with hardly any
of the lungs capable of ventilation, accompanied by the presence of pleural fluid
in the thorax. The auricles were much enlarged. Also one adrenal was 3 or 4
times larger than normal with a swollen adrenal artery. Histological examination
of this gland showed a picture suggestive ofmedullary phaeochromocytoma.
Gillman, Gilbert and Spence (1953) report that in rats reared from animals
derived from the Wistar Institute phaeochromocytomas were found in 76 per cent
females and 85*5 per cent males aged 25 months or more. The incidence in other
strains of rats is often not nearly so high, but it is very possible that the phaeo-
chromocytoma found in this study was spontaneous and not related to the
treatment with 3-hexenolactone. The same authors report an incidence of 14
thyroid carcinomas in 327 rats aged 13-32 months which further suggests that
the thyroid carcinomas also arose spontaneously in our penicillin treated group.
(Chemical Properties of the Lactones Used
Condensation of/3-propiolactone with cysteine
L-Cysteine hydrochloride (3 14 g., 0.02 moles) was dissolved in 40 ml. water,
neutralized to bromothymol blue by sodium hydroxide (9-6 ml. 2 N), and stirred
with a solution of/I-propiolactone (1.44 g., 0 02 mole, redistilled) in 20 ml. water.
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The mixture became acidic and was titrated with 2 N NaOH at frequent intervals
to maintain neutrality: 50 per cent of the calculated amount was required after
7 minutes at 200, and 92 per cent after 2-5 hours, when hydrochloric acid (10 ml.
2 N) was added and the filtered solution was concentrated in vacuo until crystals
appeared. After leaving at +-4° overnight the crystalline compound was collected
by filtration, washed with a little water and dried in vacuo. Total yield 2-88 g.
nearly pure material, m.p. 196° decomp., or 73 per cent of calculated. After one
recrystallization from a little hot water, 2-45 g. material (A) m.p. 210-212° un-
corrected, decomp., was obtained. Analysis (Weiler and Strauss, Oxford):
Found: C, 37-0 H, 5.7 N, 7-27 ; S, 1641 per cent. Calculated for C6H11O4NS:
C, 37.2; H, 5-7; N, 7-35; S, 166 per cent. The formula is that of S-2-carboxy-
ethyl-L-cysteine, of which a sample (B) kindly supplied by Dr. P. Mamalis
(Mamalis et al., 1960) had m.p. (uncorr.) 210-212° (decomp.); mixed m.p. un-
changed. The N-benzoyl derivative was prepared by treatment with benzoyl
chloride in alkali and had m.p. 103-105° (Mamalis et al., 1960, give 106-5-108°),
mixed m.p. 103-105°. Analysis (Weiler and Strauss); Found: C, 52-8; H,
5-22; N, 4-84 per cent. C13H1505NS requires C, 52X8; H, 5X1 ; N, 4-7 per cent.
The colour value of the unbenzoylated product with ninhydrin, after heating at
1000 for 15 minutes, was per mole 90 per cent of that given by pure leucine, indi-
cating one free oc-amino group in the molecule. The nitroprusside test for thiol
group was negative. On paper chromatography, both before and after oxidation
(? to the sulphoxides) with dilute hydrogen peroxide, and whether run in phenol/
water or butanol/acetic acid, the RF values were virtually identical with those
obtained with the sample of S-2-carboxyethyl-L-cysteine of Mamalis et al. (1960):
RFin:
Phenol/water BuOH/acetic
fl-Propiolactone product (A) 041 0 44
S-Carboxyethyl cysteine (B) 041 0*46
Oxidized product (A) . . 027 0-26
Oxidized product (B) . 0 27 0 26
We are greatly indebted to Dr. J. K. Whitehead for these measurements and
for assistance in identification of our product.
Consequently the reaction of /8-propiolactone with cysteine may be written:
R. S CH2 CH2 R. S.CH2-CH2
H O CO COOH
where R- is HOOC . CH(NH2) . CH2 ofcysteine, and R . S H the mercaptide
ion.
Rates of hydrolysis of the lactones
The rates of hydrolysis were measured:
(a) In bicarbonate buffer at 370 and pH approximately 7 in Warburg mano-
meters in an atmosphere of nitrogen containing 5 per cent carbon dioxide.
(b) By titration at 250 with carbon dioxide-free sodium hydroxide and phenol-
phthalein as indicator.
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Rates of reaction of the lactones with aqueous cysteine at approximately neutral
reaction
These rates were measured:
(a) By mixing, from the side bulb of a Warburg vessel, the lactone (usually
20 ,tmoles) with a solution of cysteine (20 ,tmoles) in 0 025 M sodium bicarbonate
at 25° under nitrogen/5 per cent C02, and measuring the acid production mano-
metrically as the CO2 evolved.
(b) By measurement of free sulphydryl in a mixture, as under (a), by means
of N-ethyl maleimide (Roberts and Ronser, 1958).
(c) By a similar reaction but with the use of the method of Sullivan, Hess and
Howard (1942) for cysteine estimation.
This variety of methods was necessary because the lactones variously inter-
fered with the colour reactions and with several of them the nitroprusside test,
for example, was brown instead of purple and the results were completely un-
reliable.
The approximate relative rates of hydrolysis and of reaction with the sulphy-
dryl group of cysteine are summarized in Table V.
TABLE V.-Rates of Hydrolysis and of Reaction with Cysteine of the Lactones
Rate of reaction with cysteine
Rate of
Lactone hydrolysis Acid production Loss of SH
I /-Propiolactone . . + + + c + + +
II . Patulin. . . _ . + +
III Penicillic acid . instantaneousb . + +e
IV . Methyl protoanemonin . ± + + +
V . 4-Hexenoic lactone . . + + + +
VI . 2-Hexenoic lactone - - +
VII . Penicillin G . . . + + +d +
XI . 3-Hexenoic lactone + + + + i
XII . a-Angelica la-tone . . +++
XIII . y-Butyrolactone . - - i
a. k (unimolecular) at 25°: found 3 9 x 10-3 min1.
b. The lactone is in tautomeric equilibrium with the corresponding ketoacid, 4-keto-3-methoxy-5-
methylene-hex-2-enoic acid.
c. k (bimolecular) at 250: found = 4- 6 lit. mole-'. min-'.
d. k (bimolecular) at 23° is 4- 9 lit. mole-'. min-1. (strongly pH-dependent; Nakken et al., 1960).
e. See Geiger and Conn (1945).
DISCUSSION
As far as we are aware only /,-propiolactone among the present series of com-
pounds has hithertobeenshownto be carcinogenic. In fact, the only other member
ofthis series previously tested appears to be penicillin, ofwhich various derivatives
are cited as giving no tumours in the survey by Shubik and Hartwell (1957),
where they appear under reference numbers 755, 768, 792, 895 and 910. Most
of these penicillin derivatives were given orally, however, the longest administra-
tion being orally for 32 weeks in chicks dosed with procaine-penicillin G (Elam,
Gee and Couch, 1951) and for 29 weeks in rats with N,N'-dibenzylethylene-di-
amine penicillin (Forbes et al., 1953). The longest series of subcutaneous injec-
tions cited is only 7 weeks, a period almost certainly inadequate to elicit a carcino-
genic response in the rats used, especially as an aqueous solution (of benzyl
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penicillin /,-diethylaminoethyl ester hydriodide) was injected (Engelbreth-Holm
and Roholt, 1953).
In the present series of experiments the control rats given arachis oil did not
develop local tumours. The oil was unheated before use, unlike that used for
similar control injections into rats by Walpole et al. (1954), which was sterilized
by heating at 140° C. for 1 hour before use. These authors observed in 91 rats
so injected, 14 sarcomas at the injection site after periods of from 60-100 weeks.
Vhether the difference is related to the pre-heating of the oil or not is unknown.
In our control series also, only one tumour at a site remote from the injection
was detected.
Local tumours were produced by injection of oily solutions of substances
IIX, Tables I-IV. Without tests at higher dilutions it is not possible to attempt
more than a very provisional grading of carcinogenic activity, but this would be
approximately in descending order down the series from I to X. /3-Propiolactone
(I) was the most active, in that all survivors at a dosage of 0.1 mg. per injection
developed local sarcomas within 34 weeks. It is of interest that even in freshly
prepared aqueous solution, in which form it is fairly readily hydrolysed, fl-pro-
piolactone was also carcinogenic. Patulin(II) in doses of 0-2 mg. in oil produced
local sarcomas in 6 rats among 8 survivors, after a longer period (64-69 weeks).
Penicillic acid(III)wasnottestedindosesbelow 1 mg.,atwhichlevelitproduced
tumours in all animals alive at 67 weeks. The activity of the three lactones,
methylprotoanemonin(IV) the 2-and4-hexenolactones (V and VI) appear to be
roughly in that order, withpenicillin G (VII) and the two substituted/8-propio-
lactones (VIII and IX) rather less carcinogenically active in the doses given.
Finally it was surprising to find one sarcoma in the series of rats injected with
doses of 05 mg. of the condensation product of ,-propiolactone andcysteine,
namely S-2-carboxyethyl-L-cysteine (X) injected rats dying earlier (47, 52,
69 and 76 weeks after start ofinjections) had no tumours. We are at present
testing ,.-propiolactone hydrolysed by long standing in aqueous solution at25°
to3-hydroxypropionicacid, but asyet (45weeks) no tumours have developed in
rats given1 mg. doses of this compound. Painting ,3-bromopropionic acid on
mouse skin(Ann.Rep.Brit.Emp. CancerCampgn, 1959) gave no tumours either.
There is perhaps apossibility that the carboxyethyl radicle may become trans-
ferred in thebodyfromcompound(X), apointthatrequires investigation.
Closely related lactones which have not produced tumours in this series are
thesaturatedcompoundy-butyrolactone(XIII)andtwolactonesbothhaving the
double bond in the /3-position, namely the 3-hexenolactone (XI) andc-angelica
lactone (XII).
As aresult of thiswork, the typesof chemical structures shown in Table VI
have been provisionally allocated potentially carcinogenic or non-carcinogenic
properties:
The Romanfigures under the formulae refer to the numbers given to the repre-
sentative lactones in this paper, while the capital letters refer to the group-
formulae in Table VI.
The 4-memberedringsofthepropiolactones (A) orofpenicillin (B); and also
the various hexenolactones (C, DandE) canbe carcinogenic, but not apparently
the saturated 5-membered lactone (F) northe/-unsaturated lactones (G).
The carcinogenic activity in these series bears no obvious relationship to the
rate ofhydrolysis (Table V), but there may be a tentative indication of a cor-
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TABLE VI.-Basic Types of Chemical Structure in Relation
to Carcinogenicity
(a) Carcinogenic
C c
0 co
A
Compounds I, VIII, IX
C C C: C
C CO C- C CO
C D
Compounds 11, 1T1. IV, VII,1.V
(b) Not carcinogenic
aCf C\
\0/
F
Compounds XIII
C C
N CO
B
VIl
C C
0
E
VI
C/ C
C CO
G
Xi, Xii
relation with the reactivity with the cysteine sulphydryl group, though appar-
ently not with the extent of acid production occurring on reaction with cysteine
(Table V). It would appear desirable to make a more detailed study of the
mechanism of reaction of all these lactones with nucleophilic reagents such as
cysteine, since the overall reactions clearly belong to more than one fundamental
type. It is worth noting that among the five-membered lactones, the possibility
of conjugation of the carbonyl double bond with other double bonds already
present in the molecule (lactones II, III, IV, VI) or perhaps readily produced by
dehydrogenation (for example oflactone V, giving the doubly conjugated lactone
IV), appears tobe associatedwith carcinogenic activity inthis series ofcompounds.
A very wide range of such lactones is available, and many of them have been
found to be naturally occurring in plants, bacteria and animals (see Haynes,
1948). Although all the compounds found to be carcinogenic in this paper are
weakly so, relative to such highly active carcinogens as benzopyrene, Kennaway
(1954) and others have stressed the importance in relation to human cancer which
materials of low potency might have if they were to be either formed in animal
metabolism or taken up from external sources over long periods.
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The group of lactones and lactams of the type described in this paper need
much further study with a view to developing the relationship between chemical
structure and carcinogenesis in this series, which seems to be emerging. This
should be supplemented by a study of the effects of the lactones as antibiotics,
on mutations, as alkylating agents, and as selective growth inhibitors properties
which as we have already seen are known to be possessed by some oftheir members.
StTMMARY
1. Starting from the known carcinogenic property of /J-propiolactone, a study
has been made of the effect of twice weekly subcutaneous injection into rats of a
number of chemically and pharmacologically active lactones and related sub-
stances.
2. /J-Propiolactone given as a solution in arachis oil was found to produce
sarcomas at the site of injection in all rats surviving at 34 weeks at a dose level
of 0O1 mg. about one twentieth of that previously tested. Tested at the 2 mg.
dose level the freshly prepared aqueous solution was also carcinogenic. Two sub-
stituted f-propiolactones were weakly carcinogenic in the doses used.
3. The antibiotics patulin (clavacin) and penicillic acid were carcinogenic in
all surviving rats when tested in 0.2 mg. and 2 mg. doses respectively.
4. Penicillin G (2 mg. doses as the sodium salt) suspended in arachis oil produced
one local sarcoma in each of two separate groups of five rats.
5. Arachis oil, unheated, gave no local tumours in 20 control rats, which
showed only one tumour (thoracic) at autopsy.
6. Three synthetic unsaturated 5-membered lactones (methyl protoanemonin,
2-hexenoic acid lactone and 4-hexenoic acid lactone), in doses of 1 or 2 mg.,
produced local sarcomas on injection.
7. Attention is drawn to the properties of antibiotic action and of growth in-
hibition, and their inactivation by reaction with cysteine, shown by certain of this
group of carcinogenic agents. The interaction of /-propiolactone and cysteine
has been studied and the product isolated and identified as S-2-carboxyethyl-L-
cysteine. This substance itself had only very weak carcinogenic properties.
8. Two main types of chemical constitution appear associated with carcino-
genic activity in this series: a highly strained 4-membered ring (as in the fl-pro-
piolactones and the lactam ring in penicillin) or a lactone ring having double
bonds at the 2 or 4 position, or preferably at both. If there was no double bond,
or if it was at the 3-position, the lactones tested were inactive.
We would like to express our gratitude to Dr. A. C. Thackray for his kindness
in giving opinions on all the sections examined histologically, and also to Professor
I. Doniach for advice on the thyroid and (?)parathyroid tumours. Gifts of
materials from Professor J. H. Birkinshaw, Dr. P. Mamalis, Professor H. Oettel
and Dr. A. L. Walpole are gratefully acknowledged. Dr. J. K. Whitehead and
Dr. A. E. Kellie and Mr. D. H. Williamson kindly provided chemical advice and
help, and technical assistance was provided by Mr. S. Graves, Mr. E. D. Decker,
Miss Frances Bell and Miss Judith Cooke.
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